Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Director's Dealing 2022

Aug 31, 2022

65058_rns_2022-08-31_cbe2d012-cef3-41ad-95fe-4aba64867823.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Corrected Appendix 3Y Origi nally lodged 8 November 2021 Corrected 1 September 2022

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HEALIUS LIMITED**(Company)** Name of entity HEALIUS LIMITED**(Company)**
ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Malcolm Parmenter
Date of last notice 25 October 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 340] intentionally omitted <==

----- Start of picture text ----- Direct or indirect interest DirectAs shown in relation to ordinary sharesNature of indirect interest(including registered holder) Not applicable in relation to Performance RightsNote: Provide details of the circumstances givingrise to the relevant interest. Not applicable in relation to OptionsDate of change 8 November 2021Malcolm W Parmenter Pty Ltd59,597atf Malcolm W ParmenterOrdinary sharesSuperannuation Fund776,480Malcolm ParmenterOrdinary sharesNo. of securities held prior tochange 101,034Employee ServiceMalcolm ParmenterRights11,081,391Malcolm ParmenterOptionsClass Ordinary sharesNumber acquired Nil----- End of picture text -----

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

==> picture [434 x 311] intentionally omitted <==

----- Start of picture text ----- Number disposed 143,193 154,553 fully paid Ordinary sharesValue/ConsiderationNote: If consideration is non-cash, provide details $4.98 per shareand estimated valuationMalcolm W Parmenter Pty Ltd59,597atf Malcolm W ParmenterOrdinary sharesSuperannuation Fund633,287621,927 Malcolm ParmenterNo. of securities held after Ordinary shareschange101,034Employee Service Malcolm ParmenterRights11,081,391Malcolm ParmenterOptionsNature of change On-market trade (during trading window) to meet taxExample: on-market trade, off-market trade, obligations arising from allocation of securities inexercise of options, issue of securities under September and October 2021 as part of Dr Parmenter’sdividend reinvestment plan, participation in buy-back remuneration package.----- End of picture text -----

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed period whereprior written clearance was required? Not applicable
If so, was prior written clearance provided to allow thetrade to proceed during this period? Not applicable
If prior written clearance was provided, on what datewas this provided? Not applicable

Authorised by: Charles Tilley Company Secretary

Date: 8 November 2021 Corrected 1 September 2022

[Note: this Appendix 3Y supersedes the Appendix 3Y lodged on 8 November 2021 in respect of Dr Malcolm Parmenter. The number of disposed shares has been corrected from 143,193 fully paid Ordinary shares to 154,553 fully paid Ordinary shares and number of securities held after the change from 633,287 Ordinary Shares to 621,927 Ordinary shares.]

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011